Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study
Blood
- Blinatumomab
- JAK–STAT signalling
- B-cell acute lymphoblastic leukemia
- Clonal hematopoiesis of indeterminate potential
- Minimal residual disease
- Humans
The paper
钟晓明, Kathryn G. Roberts, Huimei Wei, Charles Grenfell Mullighan
Show 58 more authors
Zhuoxin Sun, Lindsey E. Montefiori, Amit Kumar, Ilaria Iacobucci, Pradyumna Baviskar, Qingsong Gao, Petri Pölönen, Shondra M. Pruett‐Miller, Rori Schreiber, Ti‐Cheng Chang, Wenchao Zhang, Shaohua Lei, Evadnie Rampersaud, Yiping Fan, Gang Wu, Ryan J. Mattison, Yanming Zhang, Janis Racevskis, Hillard Michael Lazarus, Jacob M. Rowe, Daniel A. Arber, Matthew Joseph Wieduwilt, Yasser Abou Mourad, Paul J. Shami, Maria R. Baer, Adam Steven Asch, Kristen Marie O’Dwyer, Aric C. Hall, Michaela Liedtke, Julie Bergeron, Brent Lee Wood, Keith William Pratz, Shira Naomi Dinner, Noelle V. Frey, Steven D. Gore, Bhavana Bhatnagar, Ehab L. Atallah, Geoffrey L. Uy, Deepa Jeyakumar, Tara L. Lin, Cheryl L. Willman, Nikolai Alexandrovich Podoltsev, Daniel J. DeAngelo, Shejal Patel, Michelle Ann Elliott, Anjali S. Advani, Dimitrios Tzachanis, Pankit J. Vachhani, Rupali Roy Bhave, Elad Sharon, Richard F. Little, Harry Paul Erba, Richard M. Stone, Martin S. Tallman, Jun J Yang, Selina M. Luger, Elizabeth Paietta, Mark Robert Litzow,St. Jude Children's Research Hospital
Blood · 5 Oct 2026
